NRX Pharmaceuticals, Inc. (NRXP) stock
NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.45+0.30 (+13.95%)
Close on Nov 17, 2026Market cap $106.08MP/E –Yield –
NRX Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
NRX Pharmaceuticals's total debt was $9.16M at Dec 31, 2023. For fiscal 2023 it was $9.16M, down 13.0% from the year before. The highest annual figure on record is $10.53M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $9.16M | -13.0% |
| FY2022 | Dec 31, 2022 | $10.53M | +585.4% |
| FY2019 | Dec 31, 2019 | $1.54M | +122.6% |
| FY2018 | Dec 31, 2018 | $690.00K | – |
| FY2017 | Dec 31, 2017 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $9.16M | -13.0% |
| Q3 FY2023 | Sep 30, 2023 | $10.07M | +555.7% |
| Q2 FY2023 | Jun 30, 2023 | $12.69M | +1739.4% |
| Q1 FY2023 | Mar 31, 2023 | $12.19M | – |
| Q4 FY2022 | Dec 31, 2022 | $10.53M | – |
| Q4 FY2019 | Dec 31, 2019 | $1.54M | – |
| Q4 FY2018 | Dec 31, 2018 | $690.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
See a number that looks wrong?